Home

Alexander A Zukiwski

CIK 1569782 · EVP and Chief Medical Officer · last filed 2022-09-09

Alexander A Zukiwski is an EVP and Chief Medical Officer who has filed 12 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing, for CASI, was dated Sep 9, 2022.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

12

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
200 ROUTE 31 NORTH
SUITE 104
FLEMINGTON, NJ 08822
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CASI Pharmaceuticals, Inc. (CASI) Delisted EVP and Chief Medical Officer — $0.28 — $0 4 2022-09-09

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-09-09 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2021-12-06 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2019-12-17 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2017-04-05 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2016-04-11 — Grant (A) — $0
2016-01-14 — Buy (P) +144,806 $50.7K
2014-01-28 — Grant (A) — $0
2013-11-08 — Grant (A) — $0
2013-10-31 — Mixed +113,318 $172.0K
2013-05-30 — Other (J) +9,667 $2.9K
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.